Published in Mol Pharmacol on November 16, 2010
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
Molecular signatures of G-protein-coupled receptors. Nature (2013) 5.19
Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci (2011) 1.42
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev (2015) 0.88
A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design. Br J Pharmacol (2013) 0.88
From molecular details of the interplay between transmembrane helices of the thyrotropin receptor to general aspects of signal transduction in family a G-protein-coupled receptors (GPCRs). J Biol Chem (2011) 0.86
Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi. J Biol Chem (2013) 0.85
Modulation of constitutive activity and signaling bias of the ghrelin receptor by conformational constraint in the second extracellular loop. J Biol Chem (2012) 0.83
Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues. Br J Pharmacol (2013) 0.81
Amino acid conservation and interactions in rhodopsin: probing receptor activation by NMR spectroscopy. Biochim Biophys Acta (2013) 0.80
TMalphaDB and TMbetaDB: web servers to study the structural role of sequence motifs in α-helix and β-barrel domains of membrane proteins. BMC Bioinformatics (2015) 0.78
Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism. J Biol Chem (2014) 0.78
Three "hotspots" important for adenosine A(2B) receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loop. Purinergic Signal (2011) 0.77
Ligand chain length drives activation of lipid G protein-coupled receptors. Sci Rep (2017) 0.75
Functional roles of T3.37 and S5.46 in the activation mechanism of the dopamine D1 receptor. J Mol Model (2017) 0.75
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist. Nature (2012) 6.18
Molecular signatures of G-protein-coupled receptors. Nature (2013) 5.19
Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci (2007) 5.18
Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol (2006) 3.76
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature (2010) 3.19
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Proc Natl Acad Sci U S A (2009) 2.86
Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J Biol Chem (2005) 2.64
A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci (2004) 1.89
Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer. EMBO J (2009) 1.86
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature (2010) 1.79
Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol (2008) 1.73
Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A (2006) 1.71
The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov (2005) 1.67
Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy. Proc Natl Acad Sci U S A (2012) 1.57
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther (2005) 1.52
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest (2010) 1.50
The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. Chembiochem (2007) 1.47
Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annu Rev Pharmacol Toxicol (2007) 1.42
Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J (2003) 1.35
Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor. J Med Chem (2011) 1.30
Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nat Neurosci (2010) 1.30
A G(q/11)-coupled mutant histamine H(1) receptor F435A activated solely by synthetic ligands (RASSL). J Biol Chem (2005) 1.29
Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors. Mol Pharmacol (2009) 1.29
The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res (2009) 1.28
HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks. Trends Pharmacol Sci (2005) 1.27
The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci (2005) 1.26
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol (2009) 1.25
The carboxyl terminus of human cytomegalovirus-encoded 7 transmembrane receptor US28 camouflages agonism by mediating constitutive endocytosis. J Biol Chem (2003) 1.20
Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo. J Med Chem (2008) 1.20
Keynote review: histamine H3 receptor antagonists reach out for the clinic. Drug Discov Today (2005) 1.19
Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin. J Med Chem (2007) 1.18
Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. J Biol Chem (2010) 1.15
Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology (2008) 1.15
Ser and Thr residues modulate the conformation of pro-kinked transmembrane alpha-helices. Biophys J (2004) 1.14
Linking agonist binding to histamine H1 receptor activation. Nat Chem Biol (2005) 1.14
Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J Biol Chem (2002) 1.13
Towards small-molecule CXCR3 ligands with clinical potential. ChemMedChem (2008) 1.11
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc Natl Acad Sci U S A (2010) 1.11
Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis. J Med Chem (2009) 1.11
Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. J Med Chem (2004) 1.10
Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors. J Biol Chem (2003) 1.10
Transforming fragments into candidates: small becomes big in medicinal chemistry. Drug Discov Today (2009) 1.09
An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor. J Biol Chem (2005) 1.08
Molecular basis of ligand dissociation in β-adrenergic receptors. PLoS One (2011) 1.06
Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol (2002) 1.05
Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol (2007) 1.04
Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists. Bioorg Med Chem Lett (2004) 1.04
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. J Med Chem (2011) 1.03
Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking. J Med Chem (2006) 1.03
The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation. J Biol Chem (2008) 1.01
The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning. J Biol Chem (2010) 1.01
The human cytomegalovirus-encoded chemokine receptor US28 induces caspase-dependent apoptosis. FEBS J (2005) 1.01
CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. J Biol Chem (2004) 1.01
Influence of the environment in the conformation of alpha-helices studied by protein database search and molecular dynamics simulations. Biophys J (2002) 1.01
Real-time visualization of heterotrimeric G protein Gq activation in living cells. BMC Biol (2011) 1.00
The rat cytomegalovirus R33-encoded G protein-coupled receptor signals in a constitutive fashion. J Virol (2002) 1.00
Impact of helix irregularities on sequence alignment and homology modeling of G protein-coupled receptors. Chembiochem (2012) 1.00
Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors. Mol Pharmacol (2006) 1.00
Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes. J Biol Chem (2003) 1.00
The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. J Virol (2005) 1.00
Fragment growing induces conformational changes in acetylcholine-binding protein: a structural and thermodynamic analysis. J Am Chem Soc (2011) 1.00
Ubiquitination of CXCR7 controls receptor trafficking. PLoS One (2012) 1.00
Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1. J Med Chem (2012) 0.99
Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms. Mol Pharmacol (2006) 0.99
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors. J Pharmacol Exp Ther (2008) 0.99
Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens. Eur J Pharmacol (2004) 0.98
Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach. J Med Chem (2008) 0.98
Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor. J Biol Chem (2002) 0.97
Synthesis and structure-activity relationship of the first nonpeptidergic inverse agonists for the human cytomegalovirus encoded chemokine receptor US28. J Med Chem (2005) 0.96
Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J Allergy Clin Immunol (2007) 0.96
Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor. Biochem J (2008) 0.96
Antinociceptive activity of chemical congeners of improgan: optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic. Neuropharmacology (2006) 0.96
Computational study of ground-state chiral induction in small peptides: comparison of the relative stability of selected amino acid dimers and oligomers in homochiral and heterochiral combinations. J Comput Chem (2006) 0.96
Online fluorescence enhancement assay for the acetylcholine binding protein with parallel mass spectrometric identification. J Med Chem (2010) 0.96
Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively. Pharmacol Biochem Behav (2007) 0.96
Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. EMBO Rep (2013) 0.95
Viral hijacking of human receptors through heterodimerization. Biochem Biophys Res Commun (2008) 0.95